# How does Adropin relate to cardiovascular aging and vascular function?

Canonical source: https://retacompare.com/research/how-does-adropin-relate-to-cardiovascular-aging-and-vascular-function

Peptide Longevity Q&A · 2026-03-01


    Research indicates that serum adropin levels are significantly lower in patients with systemic lupus erythematosus (SLE) compared to healthy individuals. This decrease is associated with hypertension and may suggest a role for adropin as a predictor of cardiovascular disease in this population.

What the research shows

The study explored variations in serum adropin levels among patients diagnosed with systemic lupus erythematosus (SLE), a complex autoimmune disease. It included a cross-sectional analysis of 59 SLE patients and 30 age-matched healthy controls. Serum adropin levels were measured using high sensitivity human ELISA kits. The results showed that SLE patients had significantly lower serum adropin levels (0.41 ng/mL) compared to controls (0.69 ng/mL), with a p-value of 0.001. Additionally, lower adropin levels were noted in SLE patients with hyperlipidemia, hypertension, nephritis, serositis, hypocomplementemia, and positive anti-phospholipid antibodies (APLAs). Interestingly, female SLE patients exhibited higher serum adropin levels. The study also found a significant negative correlation between serum adropin levels and disease duration. Multiple linear regression analysis retained an association between serum adropin levels, hypertension, and positive APLAs.

Why it matters for longevity

The findings from this study highlight the potential role of adropin in cardiovascular health, particularly in populations with autoimmune diseases like SLE. Given that cardiovascular disease is a leading cause of morbidity and mortality, understanding the mechanisms by which adropin influences vascular function and inflammatory processes could have significant implications for longevity. The observed decrease in adropin levels in SLE patients suggests a potential biomarker for assessing cardiovascular risk in this demographic. As adropin is involved in lipid and glucose metabolism, its regulation may also influence overall metabolic health, further impacting longevity.

Key findings at a glance

Serum adropin levels are significantly lower in SLE patients compared to healthy controls.

Mean serum adropin levels were 0.41 ng/mL in SLE patients versus 0.69 ng/mL in controls.

Lower adropin levels are associated with hypertension and other clinical manifestations of SLE.

Female SLE patients showed higher serum adropin levels than their male counterparts.

A significant negative correlation exists between serum adropin levels and disease duration.

Adropin may serve as a potential predictor of coronary artery disease in rheumatic diseases.

How Adropin works (background)

Adropin is a peptide hormone that plays a critical role in regulating lipid and glucose metabolism. It is known to exhibit protective effects against oxidative stress and inflammation, which are key factors in the development of cardiovascular diseases. By modulating immune responses, adropin may influence the inflammatory pathways that contribute to vascular dysfunction. This peptide's ability to regulate metabolic processes suggests that it could be a significant player in maintaining cardiovascular health, particularly in populations at risk for metabolic syndrome and cardiovascular diseases.

Safety, caveats, and what we don't yet know

While the study provides valuable insights into the relationship between adropin levels and systemic lupus erythematosus, it is important to note that the research is cross-sectional and does not establish causation. The sample size is relatively small, and further studies are needed to confirm these findings in larger cohorts. Additionally, the study primarily focuses on women, which may limit the generalizability of the results to other populations. Future research should explore the effects of adropin in various demographics and its potential therapeutic applications in cardiovascular health.

Bottom line

The significant decrease in serum adropin levels in patients with systemic lupus erythematosus suggests its potential role as a biomarker for cardiovascular risk, particularly in individuals with autoimmune diseases.

Related questions

Can Adropin improve metabolic health in older adults?

Research suggests that adropin plays a role in regulating lipid and glucose metabolism, which could be beneficial for metabolic health in older adults, although specific studies are needed to confirm this effect.

How does Adropin affect inflammation in aging populations?

Adropin has protective effects against oxidative stress and inflammation, indicating that it may help mitigate inflammatory processes associated with aging, but more research is required to clarify these effects in older populations.

What is the role of Adropin in cardiovascular disease?

Adropin is associated with cardiovascular health, particularly in autoimmune conditions like SLE. Lower levels may indicate increased cardiovascular risk, suggesting a potential role in disease prediction and management.

Source: PubMed · Health Sci Rep · published 2026-03-01.

## Sources

- PubMed · Health Sci Rep: https://pubmed.ncbi.nlm.nih.gov/41773211/